{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:40Z","timestamp":1792425520769,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02074-0","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:10:28Z","timestamp":1762999828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between serum uric acid to creatinine ratio with metabolic profile in subjects with non-alcoholic fatty liver disease (NAFLD)"],"prefix":"10.1186","volume":"25","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer Saleem","family":"Alshkarchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Kamil","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah Suliman","family":"Maashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa Abbas","family":"Al-Khafaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hjazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chou-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam R.","family":"Kadhum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faria","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"1","key":"2074_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"4","key":"2074_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan N, H\u00e4ring H-U, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7(4):313\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2074_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"2","key":"2074_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443344","volume":"9","author":"European Association for the Study of the Liver EAftSoD","year":"2016","unstructured":"European Association for the Study of the Liver EAftSoD. European association for the study of Obesity. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes Facts. 2016;9(2):65\u201390.","journal-title":"Obes Facts"},{"issue":"8","key":"2074_CR5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"5","key":"2074_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"2074_CR7","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"issue":"14","key":"2074_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E. 10.1056\/NEJMra0912063. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350.","journal-title":"N Engl J Med"},{"issue":"6\u20137","key":"2074_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6\u20137):608\u201319.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"11","key":"2074_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang D-H, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99(11):759\u201366.","journal-title":"Heart"},{"issue":"1","key":"2074_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000443815","volume":"28","author":"B Kierey","year":"2016","unstructured":"Kierey B. Die eigenen Lebenskr\u00e4fte unterst\u00fctzen: Mikrobielle Pflanzenkr\u00e4fte-ein MRSA-Fall in der ambulanten Pflege. Schweizerische Z f\u00fcr Ganzheitsmedizin\/Swiss J Integr Med. 2016;28(1):26\u20138.","journal-title":"Schweizerische Z f\u00fcr Ganzheitsmedizin\/Swiss J Integr Med"},{"issue":"10","key":"2074_CR12","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933\u201353.","journal-title":"Clin Chem"},{"key":"2074_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cca.2021.06.006","volume":"520","author":"MM Garrido","year":"2021","unstructured":"Garrido MM, Ribeiro RM, Pinheiro LC, Holdenrieder S, Guimar\u00e3es JT. The prostate health index (PHI) density: are there advantages over PHI or over the prostate-specific antigen density? Clin Chim Acta. 2021;520:133\u20138.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2074_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.numecd.2023.05.004","volume":"33","author":"T Cao","year":"2023","unstructured":"Cao T, Tong C, Halengbieke A, Ni X, Tang J, Zheng D, et al. Serum uric acid to creatinine ratio and metabolic syndrome in middle-aged and elderly population: based on the 2015 CHARLS. Nutrition. Metabolism Cardiovasc Dis. 2023;33(7):1339\u201348.","journal-title":"Metabolism Cardiovasc Dis"},{"issue":"18","key":"2074_CR15","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971\u20131992. JAMA. 2000;283(18):2404\u201310.","journal-title":"JAMA"},{"issue":"1","key":"2074_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"key":"2074_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 2016;29:3\u20138.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2074_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/rheumatology\/kes223","volume":"52","author":"C-F Kuo","year":"2013","unstructured":"Kuo C-F, See L-C, Yu K-H, Chou I-J, Chiou M-J, Luo S-F. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology. 2013;52(1):127\u201334.","journal-title":"Rheumatology"},{"issue":"1","key":"2074_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-024-01793-0","volume":"25","author":"M Oh","year":"2025","unstructured":"Oh M, Cho SH. Serum uric acid to creatinine ratio as a predictor of insulin resistance, \u03b2 cell function, and metabolic syndrome in normal Korean adults: a cross-sectional study. BMC Endocr Disorders. 2025;25(1):1\u20138.","journal-title":"BMC Endocr Disorders"},{"issue":"1","key":"2074_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements. 2013;3(1):1\u2013150.","journal-title":"Kidney Int Supplements"},{"issue":"5","key":"2074_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1381\/096089204323093408","volume":"14","author":"CC Mottin","year":"2004","unstructured":"Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14(5):635\u20137.","journal-title":"Obes Surg"},{"issue":"8","key":"2074_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE. International physical activity questionnaire: 12- country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"2074_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12889-023-17511-9","volume":"24","author":"SM Ajabnoor","year":"2024","unstructured":"Ajabnoor SM, Jambi H, Bahijri S. Development and validation of a food frequency questionnaire in adult Saudi subjects in Jeddah City. BMC Public Health. 2024;24(1):9.","journal-title":"BMC Public Health"},{"issue":"7","key":"2074_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"key":"2074_CR25","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Routledge; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"1","key":"2074_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12872-019-1026-2","volume":"19","author":"N Ali","year":"2019","unstructured":"Ali N, Rahman S, Islam S, Haque T, Molla NH, Sumon AH, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19(1):42.","journal-title":"BMC Cardiovasc Disord"},{"issue":"12","key":"2074_CR27","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"D-H Kang","year":"2005","unstructured":"Kang D-H, Park S-K, Lee I-K, Johnson RJ. Uric acid\u2013induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"2074_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-1026-2","volume":"19","author":"N Ali","year":"2019","unstructured":"Ali N, Rahman S, Islam S, Haque T, Molla NH, Sumon AH, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19:1\u20137.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"2074_CR29","doi-asserted-by":"publisher","first-page":"e105610","DOI":"10.1371\/journal.pone.0105610","volume":"9","author":"G Tarantino","year":"2014","unstructured":"Tarantino G, Costantini S, Finelli C, Capone F, Guerriero E, La Sala N, et al. Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with nonalcoholic fatty liver disease. PLoS ONE. 2014;9(9):e105610.","journal-title":"PLoS ONE"},{"issue":"5","key":"2074_CR30","first-page":"7673","volume":"8","author":"J Cai","year":"2015","unstructured":"Cai J, Zhang S, Huang W. Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis. Int J Clin Exp Med. 2015;8(5):7673\u20138.","journal-title":"Int J Clin Exp Med"},{"key":"2074_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2015.12.028","volume":"246","author":"L Bhatia","year":"2016","unstructured":"Bhatia L, Scorletti E, Curzen N, Clough GF, Calder PC, Byrne CD. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. Atherosclerosis. 2016;246:13\u201320.","journal-title":"Atherosclerosis"},{"issue":"48","key":"2074_CR32","doi-asserted-by":"publisher","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, Sanchez-Lozada LG, Choi Y-J, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver. J Biol Chem. 2012;287(48):40732\u201344.","journal-title":"J Biol Chem"},{"key":"2074_CR33","doi-asserted-by":"publisher","first-page":"780496","DOI":"10.3389\/fphar.2022.780496","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Hong W, Lu S, Li Y, Guan Y, Weng X, et al. The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment. Front Pharmacol. 2022;13:780496.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2074_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/oby.2006.43","volume":"14","author":"JL Kuk","year":"2006","unstructured":"Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity. 2006;14(2):336\u201341.","journal-title":"Obesity"},{"issue":"2","key":"2074_CR35","doi-asserted-by":"publisher","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiology-Cell Physiol. 2007;293(2):C584\u201396.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"3","key":"2074_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ajcn\/84.3.475","volume":"84","author":"RR Wolfe","year":"2006","unstructured":"Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84(3):475\u201382.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2074_CR37","first-page":"309570","volume":"2014","author":"O Addison","year":"2014","unstructured":"Addison O, Marcus RL, LaStayo PC, Ryan AS. Intermuscular fat: a review of the consequences and causes. Int J Endocrinol. 2014;2014(1):309570.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2074_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2215\/CJN.05030610","volume":"6","author":"JH Ix","year":"2011","unstructured":"Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, et al. Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clin J Am Soc Nephrol. 2011;6(1):184\u201391.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2074_CR39","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/oby.22000","volume":"25","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Kuwabara R, Hisatome I, Niwa K, Roncal-Jimenez CA, Bjornstad P, et al. Metabolically healthy obesity and hyperuricemia increase risk for hypertension and diabetes: 5-year Japanese cohort study. Obes (Silver Spring Md). 2017;25(11):1997\u20132008.","journal-title":"Obes (Silver Spring Md)"},{"key":"2074_CR40","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.2147\/DMSO.S481233","volume":"17","author":"R Liu","year":"2024","unstructured":"Liu R, Li Z, Zhang Y, Du M, Wang X, Zhang S, et al. Association of serum uric acid with indices of insulin resistance: proposal of a new model with reference to gender differences. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2024;17:3783\u201393.","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"issue":"1","key":"2074_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00424-021-02606-2","volume":"474","author":"Z Bahadoran","year":"2022","unstructured":"Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection. Pflug Arch: Eur J Physiol. 2022;474(1):83\u201398.","journal-title":"Pflug Arch: Eur J Physiol"},{"issue":"1","key":"2074_CR42","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1038\/s41598-025-93141-y","volume":"15","author":"C De Matteis","year":"2025","unstructured":"De Matteis C, Novielli F, Di Buduo E, Arconzo M, Gadaleta RM, Cariello M, et al. Atherogenic index of plasma identifies subjects with severe liver steatosis. Sci Rep. 2025;15(1):9136.","journal-title":"Sci Rep"},{"key":"2074_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2024.10.014","volume":"131","author":"C De Matteis","year":"2025","unstructured":"De Matteis C, Crudele L, Di Buduo E, Cantatore S, Gadaleta RM, Cariello M, et al. Hyperhomocysteinemia is linked to MASLD. Eur J Intern Med. 2025;131:49\u201357.","journal-title":"Eur J Intern Med"},{"key":"2074_CR44","doi-asserted-by":"crossref","unstructured":"Novielli F, De Matteis C, Moschetta A, Crudele L. Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scores. Expert Rev Gastroenterol Hepatol. 2025:1\u201320.","DOI":"10.1080\/17474124.2025.2557243"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02074-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:03:05Z","timestamp":1763002985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02074-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02074-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current work has been ethically approved by the Prince Sattam Bin Abdulaziz University under Project Number of PSAU\/2025\/R\/1447. The work was performed under guidelines of declaration of Helsinki and all of the subjects had signed the written informed consent before participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}